January 4, 2018 / 12:24 PM / in 9 minutes BRIEF-Chemocentryx Secures Up To $100 Million In New Capital Commitments Reuters Staff 
Jan 4 (Reuters) - Chemocentryx Inc: 
* CHEMOCENTRYX SECURES UP TO $100 MILLION IN NEW CAPITAL COMMITMENTS 
* CHEMOCENTRYX INC SAYS WILL RECEIVE $50 MILLION MILESTONE PAYMENT FROM VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA 
* CHEMOCENTRYX INC - CO ALSO ENTERS INTO $50 MILLION GROWTH CAPITAL FINANCING AGREEMENT WITH HERCULES CAPITAL 
* CHEMOCENTRYX INC SAYS ALSO ENTERS INTO $50 MILLION GROWTH CAPITAL FINANCING AGREEMENT WITH HERCULES CAPITAL 
* CHEMOCENTRYX - ‍ADDITIONAL CAPITAL TO PROVIDE FUNDING TO ADVANCE AVACOPAN THROUGH TOPLINE DATA FROM PHASE III ADVOCATE TRIAL 
* CHEMOCENTRYX INC - ADDITIONAL CAPITAL ALSO EXPECTED TO PROVIDE FUNDING​ FOR‍ POTENTIAL REGISTRATION FILINGS IN U.S. AND EU. Source text for Eikon: Further company coverage: